Neopharmed Gentili SpA (NEGENT)

No results found for "".

Neopharmed Gentili SpA (NEGENT)

C/P	Industry	Status	Ticker(s)	Issuer(s)	Size(m)		Tranches	Region	Date
HYC	HLTH	PRCD	NEGENT	Neopharmed Gentili SpA	€890		1	EMEA	Jun 18, 2026

Tranche #1Neopharmed Gentili SpA

currency

EUR

size (m)

890.000

maturity

Jun 29, 2033

type

Floating

tenor

7.000

call

1.00

registration

144A/Reg S

benchmark

3mEu

ranking

Sr. Secured

moody's

s&p

fitch

size description

re-open/tap

ipt

High 3s

ipt-pxd

-50

guidance

3mEu+325-350

spread

325

coupon

3mEu+325

spread set

price

100.00000

yield

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

Tranche Comments

First Pay: 2026-10-15; Redemption: 2033-05-29; Registration: 144A/Reg S; Comments: MWC: B+50;

Deal Comments

The deal was upsized from EUR425m to EUR890m

Use of Proceeds

Refinance existing indebtedness, fund a distribution to parent to repay a portion of the PIK Notes, and pay related fees and expenses

Hide Details

Explore all other Commentary & Deal Flow

	PRICED: Neopharmed Gentili EUR890m 7NC1 Sr Sec FRN, E+325 at par	Jun 18, 2026
	FINAL TERMS/UPSIZE: Neopharmed Gentili EUR890m 7NC1 Sr Sec FRN, E+325 at par, pxg tomorrow	Jun 17, 2026
	PX TALK: Neopharmed Gentili EUR425m 7NC1 Sr Sec FRN, E+325-350 at par, pxg today	Jun 17, 2026
	NEW ISSUE: Neopharmed Gentili EUR425m 7NC1 Sr Sec FRN, IPT High 3s	Jun 15, 2026

1 to 4 of 4

Asset Backed Securities

sector/subsector profiles

High Yield

industry/subindustry profiles

Investment Grade

industry/subindustry profiles

Neopharmed Gentili SpA (NEGENT)

Deal Details

Commentary

Deal Flow